Analgesia, CesareanALGOCESANCT07312487
Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia
An observational study of Analgesia, Cesarean, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Inadequate analgesia during cesarean section is a common condition, notably addressed by national recommendations from the SFAR (French Society of Anesthesia and Intensive Care) in 2021. Read more about this study
- Who is it for?
- Ages 18 to 40 years, women only
- Conditions the study is for
- Analgesia, Cesarean
- How many people
- 2,450 participants
- Where
- 1 siteFrance
- Study dates
- 26 Oct 2024to Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- Adult
Study population: Adult woman (age ≥18 years) giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital
Who may be able to join
- Adult woman (age ≥18 years)
- Giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital
Who cannot join
- Patient who has expressed her opposition to the reuse of her data for scientific research purposes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service d'Anesthésie Réanimation médecine Péri-Opératoire - Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091
Stefanie KOESSLER, MD, 33 3 88 12 70 90, stefanie.koessler@chru-strasbourg.fr
Stefanie KOESSLER, MD
About this study
Official title: Incidence, Associated Factors, and Management of Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia in the Maternity Wards of the Strasbourg University Hospital: a 2-year Retrospective Study
Inadequate analgesia during cesarean section is a common condition, notably addressed by national recommendations from the SFAR (French Society of Anesthesia and Intensive Care) in 2021.
The objective of this study is to identify the specific characteristics of this condition in Strasbourg in terms of risk factors and management, and then to propose a protocol for its prevention and management.
- Conditions
- Analgesia, Cesarean
- Keywords
- Analgesia During Cesarean, Spinal Anesthesia
- Medical subject headings
- Agnosia
What is being measured
The primary outcome is the main question the study is designed to answer.
General anesthesia rates
Measured: at day 1 post-operative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Dec 2025
- Study start26 Oct 2024
- Primary completionDec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Analgesia, CesareanStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 2,450 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07312487
- Sponsor's protocol ID
- 9379
- Acronym
- ALGOCESA
- Status last verified
- Dec 2025
- First submitted
- 9 Dec 2025
- Last updated
- 31 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incidence, Associated Factors, and Management of Inadequate Analgesia During Cesarean Section Under Spinal Anesthesia in the Maternity Wards of the Strasbourg University Hospital: a 2-year Retrospective Study
- ClinicalTrials.gov ID
- NCT07312487
- Acronym / sponsor ID
- ALGOCESA / 9379
- Conditions
- Analgesia, Cesarean
- Keywords
- Analgesia During Cesarean, Spinal Anesthesia
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,450 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 26 Oct 2024 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 31 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Inadequate analgesia during cesarean section is a common condition, notably addressed by national recommendations from the SFAR (French Society of Anesthesia and Intensive Care) in 2021.
The objective of this study is to identify the specific characteristics of this condition in Strasbourg in terms of risk factors and management, and then to propose a protocol for its prevention and management.
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- Adult woman (age ≥18 years) giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital
Key inclusion criteria (2 listed)
- Adult woman (age ≥18 years)
- Giving birth by cesarean section between January 1, 2021, and December 31, 2022, at the Strasbourg University Hospital
Key exclusion criteria (1 listed)
- Patient who has expressed her opposition to the reuse of her data for scientific research purposes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
General anesthesia rates
Time frame: at day 1 post-operative
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2025.
Related trials for Analgesia, Cesarean
Recruiting
Lateral QL Block vs Intrathecal Morphine for Cesarean Section
Anesthesia, Postoperative Pain
RecruitingPhase 4
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
Cesarean Delivery, Cesarean Delivery; Neuraxial Opioids
Not yet recruiting
Effect of Sacral Erector Spinae Plane Block on Quality of Recovery After Cesarean Delivery: A Prospective Randomized Controlled Trial
Pain, Postoperative Pain
Recruiting
Reducing Chronic Pain Following Cesarean Delivery
Chronic Pain, Cesarean Section Complications
Not yet recruitingObservational study
Evaluation of Consciousness Depth (qCON) and Analgesia Depth (qNOX) Indices in General Anesthesia
Cesarean Section (MeSH: D002585), Anesthesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Analgesia, Cesarean, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 31 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stefanie KOESSLER, MD (33 3 88 12 70 90, stefanie.koessler@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
General anesthesia rates (time frame: at day 1 post-operative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2025.